About SAM and SH3 domain-containing protein 3
SAM and SH3 domain-containing protein 3 (SASH3) is a protein
from Homo sapiens identified by UniProt accession
O75995, 380 residues long.
MolForge cross-references it against 0 known binders and
200 disease associations.
Target properties
| Protein name | SAM and SH3 domain-containing protein 3 |
| UniProt accession | O75995 |
| Gene | SASH3 |
| Organism | Homo sapiens |
| Length | 380 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (200)
Diseases linked to this target (Open Targets).
- immunodeficiency 102 · score 0.65
- X-Linked Combined Immunodeficiency Diseases · score 0.38
- inflammatory bowel disease · score 0.18
- Immunodeficiency · score 0.12
- cancer · score 0.08
- common variable immunodeficiency · score 0.06
- isolated agammaglobulinemia · score 0.06
- lung adenocarcinoma · score 0.06
- gamma chain deficiency · score 0.05
- T-B+ severe combined immunodeficiency due to JAK3 deficiency · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75995-F1 | alphafold | PREDICTED | 65.13 | — |
Amino-acid sequence (380 residues)
MLRRKPSNAS EKEPTQKKKL SLQRSSSFKD FAKSKPSSPV VSEKEFNLDD NIPEDDSGVP TPEDAGKSGK KLGKKWRAVI SRTMNRKMGK MMVKALSEEM ADTLEEGSAS PTSPDYSLDS PGPEKMALAF SEQEEHELPV LSRQASTGSE LCSPSPGSGS FGEEPPAPQY TGPFCGRARV HTDFTPSPYD HDSLKLQKGD VIQIIEKPPV GTWLGLLNGK VGSFKFIYVD VLPEEAVGHA RPSRRQSKGK RPKPKTLHEL LERIGLEEHT STLLLNGYQT LEDFKELRET HLNELNIMDP QHRAKLLTAA ELLLDYDTGS EEAEEGAESS QEPVAHTVSE PKVDIPRDSG CFEGSESGRD DAELAGTEEQ LQGLSLAGAP
Explore SAM and SH3 domain-containing protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets